ECRG4 and neoplasm: Previous studies reported on promoter hypermethylation and reduced expression of ECRG4 in advanced esophageal and prostate carcinomas [18,19] and on a tumor suppressor function of ECRG4 in eosophageal cancer cell lines [20].